We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Sex Hormones Influence HbA1c Levels in Non-Diabetic Population

By LabMedica International staff writers
Posted on 15 Apr 2022
Print article
Image: The ARCHITECT i2000SR immunoassay analyzer (Photo courtesy of Abbott)
Image: The ARCHITECT i2000SR immunoassay analyzer (Photo courtesy of Abbott)

Sex hormones, including estrogen, progesterone, and androgens, are synthesized by the human gonads and adrenal cortex. Their main role is to promote development of the reproductive system and maintain secondary sexual characteristics.

Glycated hemoglobin (HbA1c) has long been regarded as the gold standard for evaluating long-term blood glucose control in patients living with diabetes in clinical routines. In recent years, standardized detection of HbA1c has been constantly improved, leading to sufficient sensitivity and specificity for HbA1c as an indicator of diabetes diagnosis.

Endocrinologists at the Shanghai Jiao Tong University (Shanghai, China) and their colleagues explore the extent of influence of sex hormones on HbA1c levels in non-diabetic population. A total of 1,409 non–diabetic subjects, including 601 men and 808 postmenopausal women were recruited from the local community. Venous blood samples were collected after a 10 hour overnight fast to detect fasting blood glucose (FPG), HbA1c, fasting insulin (FINS), blood lipids [total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c)], and C-reactive protein (CRP). Additionally, all the non-diabetic subjects were tested for hemoglobin, and blood samples were collected after 75 g oral glucose tolerance test to determine the 2-h blood glucose (2hPG). All laboratory indicators were measured using the standard methods.

HbA1c level was measured by high performance liquid chromatography using the Variant II hemoglobin analyzer (Bio–Rad, Hercules, CA, USA), and hemoglobin level was measured by sodium lauryl sulfate colorimetry on the XE–2100 hematology analyzer, (Sysmex Corporation, Kobe, Japan). Serum insulin levels were measured with an electrochemiluminescence immunoassay on a Cobas e411 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). Serum estradiol (E2), total testosterone (TT), and sex hormone binding globulin (SHBG) were detected on an Architect i2000SR analyzer by chemiluminescence microparticle immunoassay (Abbott GmbH & Co. KG, Wiesbaden, Germany).

The investigators reported that the level of HbA1c was 5.6 (5.4–5.9) % in all subjects, with 5.6 (5.4–5.8) % in men and 5.7 (5.5–5.9) % in postmenopausal women. Men had a median E2 level of 99.1 (84.4–121.1) pmol/L, median TT of 20.12 (15.5–24.9) nmol/L, median bioactive testosterone (BT) of 12.5 (10.0–15.9) nmol/L, and median SHBG of 40.7 (30.4–52.8) nmol/L. Postmenopausal women had a median E2 level of 36.7 (18.4–47.7) pmol/L, median TT of 0.9 (0.8–1.2) nmol/L, median BT of is 0.3 (0.2–0.3) nmol/L, and median SHBG of 53.7 (38.8–72.8) nmol/L After adjusting for age, body mass index (BMI), and hemoglobin, E2 was positively correlated with HbA1c in men and SHBG was inversely correlated with HbA1c in women. Other hormones were not correlated with HbA1c.

The authors concluded that sex hormones influence HbA1c levels in non-diabetic population. Moreover, levels of E2 were independently and positively correlated with HbA1c in men, and those of SHBG were independently and inversely correlated with HbA1c in postmenopausal women. The study was published on April 5, 2022 in the journal BMC Endocrine Disorders.

Related Links:
Shanghai Jiao Tong University 
Bio–Rad 
Sysmex Corporation 
Roche Diagnostics 
Abbott GmbH 

Gold Supplier
All-in-One Solution for All Molecular Testing
STARlet-AIOS
New
High-Throughput Nucleic Acid Extractor
Stream SP96
New
Automated Nucleic Acid Extraction System
NuActor
New
Gold Supplier
Chemistry Analyzer
BS-600M

Print article

Channels

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more

Industry

view channel
Image: QIAGEN has acquired a majority stake in enzymes provider BLIRT S.A. (Photo courtesy of QIAGEN)

Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business

QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.